As sanctions over Iran’s disputed nuclear program have intensified over the past year, reports have documented the deteriorating humanitarian situation in Iran. Medicine, in particular, is in short supply across the country, with drugs produced in the United States and European Union the most difficult to find.
Continue reading this article by registering at no cost and get unlimited access to:
- The award-winning Middle East Lobbying - The Influence Game
- Archived articles
- Exclusive events
- The Week in Review
- Lobbying newsletter delivered weekly